Our Network of Consultants

Senior executive and consultant in Life Sciences focused on applying precision diagnostics to liquid biopsies to ascertain the molecular profile of single or multiple cells captured and enriched from blood and cerebral spinal fluid.

Experience:
- Ph.D. in molecular genetics, 20 plus years biotechnology experience in R&D, technology and product development, project and operations management, leading to the design, development, manufacture and commercial launch of RUO products, CE marked, and FDA PMA and 510(k) cleared molecular diagnostic assays.
- Broad knowledge focused on state-of-the-art technologies for application in human and molecular genetics, molecular/immuno-diagnostics, and cell biology, directed toward advancing personalized medicine in rare gene disorder and complex diseases through precision diagnostics.
- Application of strategic and tactical operations to reduce timelines and meet multi-million dollar milestones for the successful launch of multiple products from concept to commercialization.
- Managed R&D, product development, and a P&L for a $230M cell culture business.
- Developed 1 and 5 year strategic road maps for new and mature products.
- High level of interpersonal skills managing multiple disciplines for innovative cross-functional projects, which include R&D, computational biology, phase-gate product development, business and market development, clinical studies, tech transfer to manufacturing for RUO and IVD products under design control, FDA QSR and ISO 13485:2016 compliance in cGMP environments.
- “Roll up sleeves” management style to motivate, lead and mentor individuals, in small and large teams, in multi-national matrix corporations, building organizations from the ground up, and meeting project timelines and financial milestones.
- Presentations to executive management, company boards, scientific meetings, investors and multiple publications in top scientific journals
- 10 issued patents and receipt of $4.4M in NIH grants.
- Broad network of key opinion leaders in human and infectious diseases leading to collaborations and partnerships.

Capabilities:
- Transition research companies and their technologies into product development power houses, converting research projects or Research Use Only (RUO) products for use as Laboratory Developed Tests (LDTs) or In-Vitro Diagnostic (IVD) medical devices.
- Develop end-to-end processes, from feasibility to validation via the IVD (510k or PMA) or LDT route for molecular and cellular diagnostic tests.
- Serve at the intersection of assessing technology in M&As.
- Generate focused strategy plans from Marketing (VOC) to Product Development of VOC generated diagnostic assays, to the transfer of developed assays, to Manufacturing/Operations for the manufacture of medical devices under ISO13485.

My area of study is the intersection of clinical neuroscience, translational pharmacology, and computational biomarker discovery. I am a PhD candidate investigating how glymphatic and meningeal–lymphatic pathways relate to neuroinflammation in humans. I focus on immune-cell phenotyping and cell-free markers that may index inflammatory activity and neurodegenerative trajectories. Alongside sampling development, I contribute to assay and workflow optimisation for mass-spectrometry-ready proteomics, with an emphasis on automation, quality control, and reproducibility.

My pharmacology and drug-safety foundation was built through an MRes in Biological Science and Translational Medicine. I examined dose- and time-dependent paracetamol-induced kidney injury in renal cell models, differentiating apoptotic and necrotic mechanisms and linking experimental readouts to clinically relevant nephrotoxicity questions. I completed a systematic review on cilastatin as a renoprotective strategy and critically evaluated in vitro acute kidney injury models for translational validity. I also gained ward-level exposure as a Clinical Research Associate in nephrology, aligning laboratory findings with real-world clinical pathways and multidisciplinary decision-making.

From an industry and communications perspective, I have experience in medical affairs-adjacent work, including market analysis to support launch planning in an ophthalmic pharmaceutical company and the development of compliant training materials with medical teams. I have delivered conference and hospital presentations, tailoring complex findings to both clinical and public audiences, and I have completed structured projects on European compliance frameworks, which underpins my approach to regulatorily aware medical writing.

Computationally, I build end-to-end machine-learning workflows in Python and R for noisy, high-dimensional datasets, particularly proteomics and multimodal clinical data. My toolkit spans supervised learning, unsupervised clustering, and dimensionality reduction.

Overall, my expertise is translating complex biomedical and quantitative evidence into actionable deliverables, supported by an MBA in Clinical Leadership and a strong biochemistry foundation, including earlier research on TEX12 expression in somatic and cancer models.

Strategic Product Management/Marketing Leader with 25+ years of experience in life sciences, specializing in product management, new product development, developing global marketing strategy within the IVD, oncology, and infectious disease markets. Extensive experience leading multifunctional teams, building stakeholder relationships, and launching products involving advanced technologies, including NGS.

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

With over 14 years of experience in the biotechnology and pharmaceutical sectors, I have established myself as a dynamic and results-driven leader, excelling in roles that demand strategic vision, scientific acumen, and exceptional project management skills. My career has been marked by significant contributions to drug discovery, innovation management, and business development, with a proven track record of driving growth and fostering client loyalty.

As Chief Business Officer in a CRO, I spearheaded business development initiatives, proactively engaging potential clients through targeted outreach campaigns. I successfully managed the entire sales cycle and secured contracts with biotech and major pharmaceutical companies. My ability to develop comprehensive proposals, aligning technical and financial aspects with client needs, ensured effective project management and client satisfaction. I represented the company's key assets at international congresses, further enhancing our market presence.

In my concurrent role as Chief Innovation Officer, I secured substantial funding for R&D projects through programs like Eurostar. My expertise in providing scientific and technical guidance to stakeholders has been instrumental in driving innovation and maintaining high standards of project execution.

Prior to these roles, as Chief Project Officer, I spearheaded drug discovery research projects, evaluating the efficacy, mechanism of action, and proof of concept for various candidates, including viruses, antibodies, small molecules, and vaccines. I managed cross-functional teams, budgets, timelines, and deliverables, ensuring project completion and regulatory compliance. My ability to analyze data and my deep expertise in flow cytometry, in vitro assays, immunology, mouse models and preclinical pharmacology evaluation allowed me to present comprehensive reports to clients and ensure project success and client satisfaction.

My academic foundation includes a PhD in immuno-oncology and a tenure as a Research Scientist at INSERM. I secured two post-doctoral grants and authored several peer-reviewed publications, further solidifying my scientific expertise.

Throughout my career, I have demonstrated a strong commitment to leadership, team collaboration, and client-centric approaches. My ability to fuse scientific knowledge with strategic business acumen has enabled me to drive impactful projects and foster long-term client relationships. I am eager to bring this unique blend of skills and experiences to new challenges, continuing to innovate and deliver exceptional results in the biotechnology and pharmaceutical sectors.

With over a decade's experience in Life Sciences, Biotechnology Commercialization and Law, I have developed a broad scope of skills in various fields, ranging from sales and marketing, to regulatory and logistic affairs. During my time as business developer, I assisted companies in establishing global distribution networks, raised global awareness through marketing campaigns, and increased sales revenue three-fold within 18 months. I have substantial experience in biotech commercialization and have successfully overseen the commercial release of more than 80 products into the global market.

I specialize in assisting companies to develop and expand their business in South Africa and other African countries. This process entails the development and implementation of a commercial strategy that is tailored for the specific territory of interest, as well as the establishment of customer and distributor networks, and guidance as to regulatory compliance and logistic considerations. I have an aptitude for relationship building, strategic planning and target customer profiling, which forms the foundation of my business development capabilities.

A distinguished life science professional with over 33 years of extensive experience in research, leadership, and innovation, adeptly navigating the complexities of the biotech and life science sectors as the founder of LMF Biosciences and currently holding key executive positions at Biosensis Pty. Limited, Symansis Limited, as well as previous roles at EMD-Millipore and Chemicon. I have demonstrated exceptional prowess in driving organizational growth, developing strategic partnerships, and leading high-impact projects across various scientific disciplines from Cell Biology and Neuroscience to Molecular Biology, Cancer, and Metabolic Disease.
My career is highlighted by significant contributions to technical and customer service excellence, playing a pivotal role in the success of major companies like Millipore and Chemicon International. My expertise encompasses a wide range of technical skills, from the basics of immunohistochemistry and western blot, DNA/RNA manipulation, molecular cloning, and PCR to a comprehensive knowledge of cell culture techniques and protein analysis, making me a respected educator and trainer in the life science community.

With a solid track record of leading multi-person teams and directing technical service organizations, I have consistently delivered world-class service, support, and scientific assistance crucial to business success in the life science reagents sector. My strategic vision and innovative approach have been instrumental in product development, customer engagement, and identifying future growth areas, enabling companies to better anticipate and meet the diverse needs of their customers.

Beyond technical expertise, my leadership roles have showcased my ability to effectively manage and expand life science markets, achieving and surpassing sales targets while fostering sustainable growth. My entrepreneurial spirit, scientific understanding, and business insight make me an invaluable asset to any organization aiming to excel in the competitive biotech and life science research reagents landscape.

In summary, I offer a unique blend of scientific excellence, strategic business management, and visionary leadership, making me an ideal candidate for roles that demand depth of knowledge, innovative thinking, and a proven track record of success in the life sciences sector.

Innovator with extensive experience and a proven track record of developing successful corporate strategies that increase revenues in the Life Sciences industry. Creative visionary and change agent who identifies growth markets, business drivers and builds collaborative global and cross-functional relationships. Recognized for combining transformational business strategies with supporting business cases, operating plans, budgets, and programs.
EXPERTISE
Strategic Planning | M&A | Financial Analysis | Partnerships and IVs | Market Assessments | Negotiation | Deal Structuring | Due Diligence
APPLICATIONS
Flow cytometry, antibodies, reagents, dyes, instruments ( sorters and analyzers)

Senior technical expertise on antibodies and immunoassays

With a thorough background of molecular cell biology and biochemistry, I have accrued multi-disciplinary knowledge and experience while working in both academic and commercial environments with an emphasis on antibodies and immunoassays. During my CSO appointment at an antibody manufacturer, I have gained global recognition on my knowledge of commercial antibodies and their validation through meetings and publications. During my time involving drugs discovery I have developed several assays and filed for patents. I have tutored and trained assistants to very high standard, and many of them have moved on the career ladder since then. After I have written SOPs in a GLP-audited CRO and many technical and managerial SOPs for a fast-growing research antibody manufacturer, my focus has been on protein biomarkers and antibody validation to industrial standard. This focus led to a thorough understanding of etiologies at protein level and of diagnostics and medical interventions. My understanding of physical, chemical, and pharmacological principles made me ready to move on as an independent consultant to aid antibody manufacturers and in vitro diagnostics industries. My interest in strategic planning has helped me thinking creatively thus providing valuable inspirations to move biotech/pharma companies forward.
Based on the above, I was in the opportunity to set up my own company to introduce a long sought after quality standard for commercial tool antibodies. This concept may ultimately also work for the early discovery of candidate therapeutic antibodies.
My expertise is now available to assist in technical or strategic hurdles when complementary experience is required. When assistance is needed for a start-up or for a well-established company, confidentiality is guaranteed, and NDAs can be exchanged when required.

30+ years of experience in the Life Sciences Industry, with particular expertise in research tools including antibodies, recombinant proteins and associated kits.
I have a PhD in Immunology, and commercial experience at Board level as Site Director, Commercial Director and Chairman. I have worked with family businesses, listed companies and PE backed companies, and have experience of developing companies to successful trade exits. My focus within industry has always been to identify new opportunities with either technology or with customers, and to execute those as quickly and effectively as possible.
Commercially I have gained in depth experience in a range of roles, and can offer advice in Business Development, Strategy, Operational and Technical areas My in-depth experience includes:-

Business Strategy
Reagent in-licensing and out-licensing
Supply agreements
Business development with major IVD and Pharmaceutical customers
Product development
P&L analysis and responsibility
Quality Systems
Developing and leading Commercial Sales and Marketing teams
Operational expertise and commercial reagent manufacturing

Having worked as a product and commercial manager for 18 years within the life science industry, my focus was always to identify cutting edge technology, applications and novel scientific companies, working with them to present their products to the wider research and IVD markets. With a skillset focused on bringing novel technologies to new markets and working to build diverse, integrated portfolios for platforms, my experience, combined with my scientific knowledge, placed me well to work within Mergers & Acquisitions on both buy side and sell side transactions along with strategic pieces.
Specialities: Biotech & Life science Consultancy, specialising in Business Development, strategy and M&A assistance.
Specialises in understanding how the scientific capabilities of companies can be presented to the life science customer base or utilised to build upon strengths of platforms for inorganic expansion.